Accessibility settings

This paper is in the following e-collection/theme issue:

Epidemiology (220) Longitudinal and Cohort Studies in Public Health (456) Infectious Diseases (non-STD/STI) (1773) Theme Issue: Human Factors of the COVID-19 Outbreak (77) Early Results from COVID-19 Studies (373)

Published on in Vol 15 (2026)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/80263, first published .
Healthcare worker scans senior man's forehead with thermometer in clinic.

COVID-19 Rebound in Nirmatrelvir Plus Ritonavir Treatment and Control Groups: Prospective Cohort Study

COVID-19 Rebound in Nirmatrelvir Plus Ritonavir Treatment and Control Groups: Prospective Cohort Study

Authors of this article:

Jacqueline K Kueper1 Author Orcid Image ;   Kalyani Kottilil1 Author Orcid Image ;   Giorgio Quer1 Author Orcid Image ;   Danielle C Chiang1 Author Orcid Image ;   Emily G Spencer1 Author Orcid Image ;   Jyothi Purushotham1, 2 Author Orcid Image ;   Edward Ramos1, 3 Author Orcid Image ;   Leila Roumani4 ;   Kristian G Andersen1, 2 Author Orcid Image ;   Eric J Topol1 Author Orcid Image ;   Jay A Pandit1 Author Orcid Image ;   Michael J Mina4, 5 Author Orcid Image
Article Authors Cited by Tweetations Metrics
All Time | Last Month | Last Six Months | Last Year
There are currently no tweets available for this article within the specified range.